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APbefors Ml improves in-hospital outcome, itaffords no benefit once patients
left the hospital.
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Stratificationin PatientawithUnetablaCoronary
ArteryDiaeaes- A TRIMaubatudy
L. Holmvang, P.Clemmensen, G. Wagner, P.Grande for the TRIM Study
Group. The Heed Centec The National University Hospital, Copenfregen,
Denmark, Duke University Medical Center, Durham, NC, USA
Unstable coronary atiefy disease, i.e. non-Q myocardial infarction and unsta-
ble angina pectoris represent a heterogeneous population of patients; some
at high risk of cardiac morbidity and mortality. The purpose of the present
study was to determine the prognostic value of risk stratification based on a
single admission ECG in patients with this syndrome.
Mehxfa.’ 472 patients from the TRIM study were included. All patients
were admitted within 24 hours of chest pain onset and treated with iv. anti-
thrombotic therapy for 72 hours after inclusion. Data: The patients were
divided into four subgroups based on the ST-segment changes in the inclu-
sion ECG: 75 (16%) had ST-elevations (with or without T-wave inversion),
59 (13%) had ST-depression (with or without T-wave inversion) 199 had iso-
lated inverted T-waves (42%) and 139 (29%) patients had no ST-changes.
Endpoints: Death, Ml, refractow angina (despite of treatment) or recurrent
angina pactoris was registered during a follow-up period of 30 days.
Raaulta: The total number of patients suffering an event was 247 (52%).
Fifty-one of these patients (11%) had a serious event (death, Ml or refractow
angina). Seventy percent of all events occurred within 72 houra after inclu-
sion. Patienta with STdepression had the highest event rate and patienta
with ST-elevation had the lowest event rate, although the event rate among
patienta with ST-elevation did not differ significantly from the patients with
no-ST-changes in the baseline ECG. The difference in event rates between
patienta with ST-depression and patients without ST-cfepressionin the base-
line ECG was highly significant (p =0.003, log rank test). A separate analysis
regarding serious cardiac events was performed, revealing a similar signifi-
cantly increased event rate among patients with ST-depression (p= 0.0003).
PatientswithST-depression at baseline hadariskof 24% forhavin98 serious
cardiac event during follow-up compared to 11%in the entire population.
Conclusion: Standard ECG ST- segment depression at inclusion were
significantly associated with increased risk of early cardiac events in patients
with unstable coronary artery disease. On the contrary, ST-elevation in this
population not undergoing thrombolytic therapy, was associated with a good
prognosis.
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D10581 HemodynamicBenefitof Long-termIntermittentUrokinaeeTherapyinEnd-ategeCoronaryArtery
Diaeaee- FiretReeultafroma GatedBloodPool
Study
B. Holz, F.C.Schoebal, T.W.Jax, P.Stark, E.G. Vester, M. Leschke,
B.E. Strauer. Department for Cardiobgx Heinrich Heine University of
DUaaeldorf,Germany
Background: Long-term intermittent urokinase therapy (UK) due to rhao-
Iogic and thrombolytic efficacy is an effective antiischemic approach for the
treatment of patients with end stage coronary artery disease and severe
angina pactoris refractory to conventional treatment. The impact of this form
of therapy on hemcdynamic parameters has not been investigated so far.
Metffoda: In a blinded study we investigated 25 patients before and after
Iong-tenmintermittent urokinase therapy (3 x 500,000 W urokinase iv. per
weak over 12weeks). All underwent a symptom-limited bicycle stress testing
with comparable level of exercise before and after treatment in combina-
tion with a gatad blood pool (GBP) analysis of left ventricular function. For
assessment of hemodynamic parameters the following were measured left
ventricular ejection fraction (EF), early systolic function (ESF) by peak ejec-
tion rate (PER)and early diastolic function (EDF) by peak filling rate (PFR)
at rest and under maximum exercise capacity.
Resu/ts: Clinkal symptoms were significantly reduced from 20.3& 5.4 to
7.2 + 2.8 angina eventa/week as well as fibrinogen levels from 338 + 43 to
207 +20 mg/dl. Hemodynamic parameters changed as follows.
Rest EF Max. EF Rest PER Max, PER Rest PFR Max, PFR
Before UK 41,2 + 14.7 43.3+ 17.5 1.9+ 0.8 2,0+ 0,9 1.5+ 0.6 2.3+ 0.9
After UK 43,8 + 14.9 52,8+ 16.7 2.3+ 0.7 2.6+ 1.1 2.2+ 0.6 3.0+ 1.3
Significance n,s. p ~ 0.01 p s 0,01 p s 0.05 p ~ 0.001 p ~ 0.01
Cone/usion:These results demonstrate that antiischemic effectiveness of
long-term intermittent urokinase therapy is also reflected by an improvement
of systolic and diastolic parameters of left ventricular performance in patients
with refractory angina pectoris.
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of RecoveryofSystolicFunctionAfter
Revaacularizetion
M.J. Williams, B. Lytle, T. Marwick. Cleveland C/inic Foundation, C/eve/and,
OH, USA
In pts with left ventricular(LV) dysfunction thetimecouraeof LVrecovety after
revascularization (RVS) is unclear. We sequentially studied LVfunction in 45
pte with severe LVdysfunction (LVEF < 35%) who underwent complete RVS
without associated valve surgery. All pts underwent resting echo pra-RVS,
earfy (2.1 + 0.9 W) and late (21 + 10 W) post-RVS. LV end-diastolic volume
(EDV), end-systolic volume (ESV) and LVEF were calculated in apical 4 and
2 chamber views using Simpson’s rule. Significant recovery of LV function
was defined as > 5% improvement in LVEF post RVS.
Resu/ta: No recovery in LV function at either early or late echo was
reportad in 16 pts (40%). These pts had a larger pre-RVS LVEDV than those
showing recovery (196 + 53 vs 161 + 40 ml, p = 0.04), but there were no
differences in clinical variables between the groups. No pt with LVEDV =-230
ml recoveredfunction. Pts who sfrowed recovery of LVfunction (n = 27) were
divided into pts who showad earfy recovery sustained at late follow-up (n =
16,36%) and pts who showed only late recovery(n = 11,24%). Pts with earty
recovety had a significantly smaller csvity eize than those who recovered
late:
Early recovey Lete recovery p value
Age (y) 61 +9 62& 7 P = NS
pre-RVS LVEF (ml) 27.8& 3,8 24.7 &4.7 p = 0.09
pre-LVEDV(ml) 134+24 200 +29 p <0.0001
Conclusion: Pts with severe LV dysfunction and large LVEDV are less
likely to recover systolic function after RVS than thoee with emaller heark..
However, pta with large LVEDV may show late recovery of syetolic function
and late follow-up is warranted.
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G.A. Lanza, A. Giordano, C. Pristipino, M.L. Calcagni, G. Maduri, C. Trani,
F. Crea, L. Troncone, A. Maseri. University’ Catto/ica, Roma, Italy
Previous work has suggested that cardiac adrenergic activity maybe abnor-
mal inpatients (pts)with syndrome X (SX, angina, STdepression on exercise,
normal coronary arteries). We assessed cardiac sympathetic nerve function
by pe~oming lzsl.metaiodobenzylguanidine (MIBG) myOCSKfialecintigraphy
in 12 SX pte (52 & 9 years, 5 men) and 10 healthy controle (53 + 5 years, 4
men). Radionuclide images were acquired 3 houra after iv. infusion of 5 mCi
(185 MBq) of MIBG. Global cardiac MIBG uptake was aseessed on planar
images by the hearUmediastinum(H/M) ratio, and a MIBG uptake ecore was
obtained from SPECT images. To this aim, the left ventricle was divided into
24 segments, an uptake score was assignad to each segment (O= normal
uptake to 3 = uptake < 50% of maximum), and total MIBG uptake score wae
obtainad as the sum of all segmental scores. On vieual inspection, an inferior
MIBG defect was only ob.sewed in 1 control subject (10%), while 9 SX pts
(75%, P < O.Ol),showed defects in MIBG uptake. Cardiac MIBG uptake was
totally absent in 4 pts, and regional defects were shown in other 5 pts, 4 of
whom also had reduced global uptake. H/M ratio was lower (1.7 +0.6 vs 2.2
+0.3, P= O.03),and MIBG uptake smre higher (35 + 31 VS4 & 2, P= O.003)
in SX pte. The Iunglmadiaetinum ratio of MIBG uptake was eimilar in the 2
groupa (1.36+ 0.2 vs 1.35 +0.2), suggesting that MIBG abnormalities were
confined to the heart in SX pts. Thus, our findings demonstrate abnormalities
in cardiac adrenergic newe function in most SX pts. These abnormalities
may contribute to several abnormal features report6d in these pta, including
coronary microvaecular dysfunction and abnormal cardiac pain sensitivity.
